Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

AstraZeneca/Merck PARP Inhibitor Approved in China for Ovarian Cancer

ICT Approved to Start US Trials of CD-19 CAR-T for Lymphoma

Bio-Thera Ok'd to Start China Trial of Biosimilar to JNJ Immune Disease Therapy

CASI's In-licensed CAR-T Candidate to Start China Trials for Leukemia/Lymphoma

Merck Announces Third Approval of Keytruda for Lung Cancer in China

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China